HARE-40

HPV anti-CD40 RNA vaccine · University of Southampton

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HARE-40, covering 2024-02-07 to 2024-02-07. Get the full timeline:

Most recent: Clinical Trial Update: HARE-40: HPV Anti-CD40 RNA vaccinE [Phase 1, Phase 2]